Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Findings from Leiden University broaden understanding of cancer vaccines
March 26th, 2008
"The interpretation of the results obtained from immunomonitoring of clinical trials is a difficult task due to the variety of methods and protocols available to detect vaccine-specific T-cell responses. This heterogeneity as well as the lack of standards has led to significant scepticism towards published results," researchers in Leiden, Netherlands report. "In February 2005, a working group was therefore founded under the aegis of the Association for Immunotherapy of Cancer (''CIMT'') in order to compare techniques and protocols applied for the enumeration of antigen-specific T-cell responses. Here we present the results from two consecutive phases of an international...
Source: Vaccine Weekly (2008-03-26)
|
